Collaborative Practice Agreement (CPA)

A CPA is a formal legal contract between a pharmacist and specific prescriber(s). It allows the pharmacist to perform clinical services —such as adjusting MOUD dosages or ordering labs—under the delegated authority of the prescriber, and typically only for patients of that prescriber.

Pros: Legal framework currently available in all US states; supports a "team-based" care model where both providers share the patient's journey.

Cons: Extremely difficult to scale because it requires finding a willing physician partner and managing individual legal agreements for every site.

Best Used For: High-touch, longitudinal care in specialized clinics or Accountable Care Organizations (ACO) where a close partnership already exists between providers.

Statewide Standing Order or Protocol

A Statewide Standing Order is a "blanket" prescription issued by a state-level official (like a Health Commissioner) that allows all licensed pharmacists in that state to provide specific services without an individual relationship.

Pros: Allows for immediate, uniform implementation across every pharmacy in the state, removing the "middleman" barrier for basic interventions.

Cons: Highly standardized and "one-size-fits-all," meaning pharmacists cannot deviate from the strict clinical steps outlined in the state-issued document.

Best Used For: Rapid public health rollouts, such as statewide naloxone distribution or COVID-19 “Test-to-Treat” initiatives

Independent Prescriptive Authority

Independent Authority is the most autonomous model, where state law recognizes pharmacists as practitioners who can prescribe certain medications (like buprenorphine) under their own license.

Pros: Maximizes patient access—especially in rural areas—by eliminating the need for a separate doctor’s visit and reducing costs for the uninsured. Provides maximum flexibility for pharmacists to provide state-of-the-art, evidence-based care. Eliminates the need to find willing prescribers for a CPA. Rapid implementation and maximum scalability.

Cons: Places the full weight of clinical liability and documentation on the pharmacist and often requires specific federal training (e.g., the 8-hour ACPE or MATE course).

Best Used For: Increasing immediate access to care and empowering pharmacists to act as the primary point of entry for OUD treatment in underserved communities.

Swipe left/right to view full table →

Feature Collaborative Practice Agreement (CPA) Statewide Standing Order / Protocol Independent Prescriptive Authority
Scalability Low: Difficult to scale; requires finding and vetting individual physician partners for every location or region. High: Easy to scale; once issued, every pharmacy in the state can implement it simultaneously. High: Seamlessly scalable; authority is tied to the professional license across the jurisdiction.
Relationship Requirement Requires a trusting relationship with a specific prescriber willing to delegate authority. No individual relationship needed; operates under a state-issued "blanket" order. No prescriber relationship required; pharmacist acts autonomously.
Authority Source Delegated by an individual prescriber or medical group. Issued by a state health official or Board. Granted directly by state law or statute.
Maintenance & Revisions High Maintenance: Must be revised/renewed each time clinical guidance or the specific agreement changes. Updated by the state entity when clinical guidelines or laws change. Updated by the state legislature or Board of Pharmacy.
Administrative Burden High: Requires contract management, periodic reviews, and individual signatures. Low: Pharmacists "opt-in" by following the state's existing protocol. Low: Once licensed/certified, no further paperwork per patient group.
Sustainability / Portability Low: If the physician leaves the practice, the agreement often becomes void. High: Consistent across the entire state regardless of local staffing changes. High: The authority stays with the pharmacist's individual license.
Documentation & Reporting Often requires sending clinical notes back to the specific delegating prescriber. Usually requires notification to a patient’s PCP or a state database. Requires standard Rx records and periodic PCP notification.
Liability Exposure Shared between the pharmacist and the delegating prescriber. Primary liability often rests with the state official/entity issuing the order. Primary liability rests solely with the pharmacist as the prescriber.

Table 1: Comparison of pharmacist authority models for providing medication for opioid use disorder (MOUD). While CPA-based models demonstrate feasibility, they are constrained by administrative, relational, and access barriers. Independent prescriptive authority via statewide standing orders or protocols enables rapid, equitable, and sustainable MOUD access through community pharmacies.